Fusion Pharmaceuticals to resume trading at 4:35 pm ET

Fusion Pharmaceuticals shares are scheduled to resume trading at 4:35 pm ET, with quotation scheduled to resume at 4:30 pm ET, according to Nasdaq. The shares were halted, news pending, ahead of the company announcing that Fusion Pharmaceuticals acquired from RadioMedix the investigational new drug application for an ongoing Phase 2 clinical trial evaluating 225Ac-PSMA I&T and that Fusion has agreed to sell an aggregate of approximately 17.6M common shares to certain accredited institutional investors in a private placement in public equity financing.